Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

OCT in Rare Chorioretinal Diseases — Stella

Home/Retinal Artery Occlusions/OCT in Rare Chorioretinal Diseases

View on ClinicalTrials.gov

Recruiting

Back to Retinal Artery Occlusions trials

OCT in Rare Chorioretinal Diseases

Trial locations(1 site)

United States

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon

Key details

Sponsor

Oregon Health and Science University

Enrollment target

~150 participants

Started

May 2014

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

7 Years – 100 Years

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.